One of ViiV Healthcare’s two-drug HIV therapies – Dovato – has been approved in Japan, providing a new treatment option for the country’s 30,000 or so people with HIV. Dovato (dolutegravir ...

ViiV’s new daily HIV treatment has been approved in the EU, as the company aims to win over patients with a more convenient treatment approach. The new regimen, dubbed Dovato, is approved in ...

Lenacapavir is already approved in multiple countries for the treatment of adults with multi-drug resistant HIV in combination ... (Cabenuva and Apretude) and Dovato.